21Shares ETPs

21Shares' commitment to promoting the positive development and institutional adoption of this new asset class is not limited to the creation of its ETPs. The company is proudly committed to offering globally recognised research material, developed with the knowledge and passion of its team. Consisting of experts specializing in various sectors of the crypto ecosystem, the team provides investors with in-depth education in the industry. On a quarterly basis, the 21Shares Research team publishes the "State of Crypto", a comprehensive report focused on a specific topic that provides updates on the cryptocurrency market.

Finally, through Analyst Call, educational webinars with 21Shares experts, you can further deepen your knowledge of the cryptocurrency market.

This document is not an offer to sell or a solicitation of an offer to buy or subscribe for securities of 21Shares AG in any jurisdiction. Neither this document nor anything contained herein shall form the basis of, or be relied upon in connection with, any offer or commitment whatsoever or for any other purpose in any jurisdiction. Nothing in this document should be considered investment advice. This document and the information contained herein are not for distribution in or into (directly or indirectly) the United States, Canada, Australia or Japan or any other jurisdiction in which the distribution or release would be unlawful. This document does not constitute an offer of securities for sale in or into the United States, Canada, Australia or Japan. The securities of 21Shares AG to which these materials relate have not been and will not be registered under the United States Securities Act of 1933, as amended (the “Securities Act”), and may not be offered or sold in the United States absent registration or an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. There will not be a public offering of securities in the United States. Neither the US Securities and Exchange Commission nor any securities regulatory authority of any state or other jurisdiction of the United States has approved or disapproved of an investment in the securities or passed on the accuracy or adequacy of the contents of this presentation. Any representation to the contrary is a criminal offence in the United States. Within the United Kingdom, this document is only being distributed to and is only directed at: (i) to investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the “Order”); or (ii) high net worth entities, and other persons to whom it may lawfully be communicated, falling within Article 49(2)(a) to (d) of the Order (all such persons together being referred to as “relevant persons”); or (iii) persons who fall within Article 43(2) of the Order, including existing members and creditors of the Company or (iv) any other persons to whom this document can be lawfully distributed in circumstances where section 21(1) of the FSMA does not apply. The securities are only available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such securities will be engaged in only with, relevant persons. Any person who is not a relevant person should not act or rely on this document or any of its contents. Exclusively for potential investors in any EEA Member State that has implemented the Prospectus Regulation (EU) 2017/1129 the Issuer’s Base Prospectus (EU) is made available on the Issuer’s website under www.21Shares.com. The approval of the Issuer’s Base Prospectus (EU) should not be understood as an endorsement by the SFSA of the securities offered or admitted to trading on a regulated market. Eligible potential investors should read the Issuer’s Base Prospectus (EU) and the relevant Final Terms before making an investment decision in order to understand the potential risks associated with the decision to invest in the securities. You are about to purchase a product that is not simple and may be difficult to understand. This document constitutes advertisement within the meaning of the Prospectus Regulation (EU) 2017/1129 and the Swiss Financial Services Act (the “FinSA”) and not a prospectus. The 2023 Base Prospectus of 21Shares AG has been deposited pursuant to article 54(2) FinSA with SIX Exchange Regulation AG in its function as Swiss prospectus review body within the meaning of article 52 FinSA. The 2023 Base Prospectus and the key information document for any products may be obtained at 21Shares AG's website (https://21shares.com/ir/prospectus or https://21shares.com/ir/kids).

---

Advertising Message for promotional purpose - This announcement does not constitute an offer to sell or a investment solicitation. Please read carefully the characteristics of the financial instruments on offer and its associated risks, which are also present in the information provided by Directa ("Preliminary information", Section C - Information on financial instruments). ETFs, ETCs and ETNs (ETPs) and Certificates are complex financial instruments, with a significant risk of loss of the invested capital and whose price may include implicit costs. Directa therefore recommends to read the product offer documentation and the KID/KIID document, which describes the operating methods, costs and risks to which you are exposed by making the investment. The term "leverage" is used to describe investment strategies aimed at multiplying potential profits and losses. Leveraged investments may be made with the aim of obtaining possible higher returns, however leverage not only amplifies gains but also any losses. The investor is also exposed to the risk of early termination of the investment and of total loss of the invested capital or even more than it. The issuer pays Directa a fee upon execution, classifiable as an inducement pursuant to the Consob Intermediaries Regulation: for this reason, a conflict of interest may occur.